SCHEMBL5375322

SCHEMBL5375322

Cc1ccc(S(=O)(=O)Nc2ccc(SCc3ccc(C(C)C)cc3)cc2)cc1C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.54
CASP6 P55212 1/20 0.48
LMNA P02545 3/20 0.47
MAPT P10636 3/20 0.47
ALDH1A1 P00352 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
PKM P14618 1/20 0.47
PABPC1 P11940 1/20 0.46
MCL1 Q07820 2/20 0.45
GFER P55789 1/20 0.45
BCL2A1 Q16548 1/20 0.45
GHSR Q92847 1/20 0.45
TDP1 Q9NUW8 1/20 0.44
KDM4E B2RXH2 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
PGR P06401 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5388054 0.90 POLB (0.56) POLBCASP6LMNAMAPTALDH1A1
Cp-778875 SCHEMBL1600965 0.90 POLB (0.58) POLBCASP6LMNAMAPTALDH1A1
SCHEMBL5386741 0.88 POLB (0.56) POLBCASP6LMNAMAPTALDH1A1
SCHEMBL14437715 0.88 POLB (0.56) POLBCASP6LMNAALDH1A1SMN1; SMN2
SCHEMBL5375209 0.88 POLB (0.58) POLBCASP6LMNAMAPTALDH1A1
SCHEMBL5373188 0.87 POLB (0.55) POLBCASP6LMNAMAPTALDH1A1
SCHEMBL5376747 0.86 POLB (0.54) POLBCASP6LMNAMAPTALDH1A1
SCHEMBL5390814 0.85 POLB (0.58) POLBCASP6LMNAMAPTALDH1A1
SCHEMBL5376861 0.85 POLB (0.56) POLBCASP6LMNAALDH1A1SMN1; SMN2
SCHEMBL5371856 0.85 POLB (0.53) POLBCASP6ALDH1A1SMN1; SMN2PABPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PFIZER INC 2006-11-16 US disclosed
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD POLB 1807/4885CASP6 3606/4885LMNA 319/4885
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARG, PPARA, PPARD POLB 2006/4885CASP6 3811/4885LMNA 565/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.